DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,756,000 | -15.2% | 17,033 | -10.6% | 0.06% | +14.0% |
| Q3 2018 | $2,070,000 | +7.8% | 19,057 | -2.1% | 0.05% | +2.0% |
| Q2 2018 | $1,920,000 | -4.1% | 19,457 | -4.8% | 0.05% | -15.5% |
| Q1 2018 | $2,002,000 | +0.4% | 20,443 | -4.9% | 0.06% | 0.0% |
| Q4 2017 | $1,995,000 | -19.5% | 21,488 | -25.7% | 0.06% | -20.5% |
| Q3 2017 | $2,479,000 | -12.8% | 28,908 | -14.1% | 0.07% | -21.5% |
| Q2 2017 | $2,842,000 | -2.6% | 33,664 | -1.4% | 0.09% | +1.1% |
| Q1 2017 | $2,919,000 | +5.4% | 34,135 | -4.1% | 0.09% | +3.4% |
| Q4 2016 | $2,770,000 | -2.3% | 35,587 | -1.6% | 0.09% | +12.7% |
| Q3 2016 | $2,836,000 | -22.4% | 36,171 | -0.1% | 0.08% | -14.1% |
| Q2 2016 | $3,656,000 | -6.5% | 36,199 | -12.2% | 0.09% | -5.2% |
| Q1 2016 | $3,912,000 | -12.1% | 41,233 | -13.9% | 0.10% | +1.0% |
| Q4 2015 | $4,450,000 | +2.2% | 47,917 | -6.3% | 0.10% | +21.5% |
| Q3 2015 | $4,356,000 | -14.7% | 51,118 | -14.3% | 0.08% | +8.2% |
| Q2 2015 | $5,105,000 | +54.6% | 59,647 | +53.3% | 0.07% | +58.7% |
| Q1 2015 | $3,303,000 | -5.6% | 38,897 | -4.7% | 0.05% | -2.1% |
| Q4 2014 | $3,499,000 | +20.0% | 40,832 | +6.4% | 0.05% | +23.7% |
| Q3 2014 | $2,916,000 | +2.5% | 38,372 | +6.2% | 0.04% | +5.6% |
| Q2 2014 | $2,845,000 | -21.6% | 36,138 | -25.4% | 0.04% | -20.0% |
| Q1 2014 | $3,631,000 | +3.9% | 48,411 | +6.9% | 0.04% | +2.3% |
| Q4 2013 | $3,495,000 | +11.8% | 45,275 | +0.4% | 0.04% | +2.3% |
| Q3 2013 | $3,126,000 | +20.3% | 45,090 | +9.8% | 0.04% | +13.2% |
| Q2 2013 | $2,599,000 | – | 41,065 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |